Co-Authors
This is a "connection" page, showing publications co-authored by Francesco Blasi and Stefano Aliberti.
Connection Strength
7.796
-
Helmet CPAP treatment in patients with COVID-19 pneumonia: a multicentre cohort study. Eur Respir J. 2020 10; 56(4).
Score: 0.908
-
COVID-19 multidisciplinary high dependency unit: the Milan model. Respir Res. 2020 Oct 09; 21(1):260.
Score: 0.907
-
Individualizing duration of antibiotic therapy in community-acquired pneumonia. Pulm Pharmacol Ther. 2017 08; 45:191-201.
Score: 0.722
-
Serum and exhaled breath condensate inflammatory cytokines in community-acquired pneumonia: a prospective cohort study. Pneumonia (Nathan). 2016; 8:8.
Score: 0.673
-
Response. Chest. 2021 06; 159(6):2507-2508.
Score: 0.237
-
SARS-CoV-2 vaccines: A critical perspective through efficacy data and barriers to herd immunity. Respir Med. 2021 Apr-May; 180:106355.
Score: 0.233
-
The Efficacy of the Mineralcorticoid Receptor Antagonist Canrenone in COVID-19 Patients. J Clin Med. 2020 Sep 11; 9(9).
Score: 0.226
-
The liaison between respiratory failure and high blood pressure: evidence from COVID-19 patients. Eur Respir J. 2020 07; 56(1).
Score: 0.224
-
Prone and Lateral Positioning in Spontaneously Breathing Patients With COVID-19 Pneumonia Undergoing Noninvasive Helmet CPAP Treatment. Chest. 2020 12; 158(6):2431-2435.
Score: 0.223
-
COVID-19 in lung transplant recipients: A case series from Milan, Italy. Transpl Infect Dis. 2020 Dec; 22(6):e13356.
Score: 0.222
-
Management of Acute Respiratory Failure Due to Community-Acquired Pneumonia: A Systematic Review. Med Sci (Basel). 2019 Jan 14; 7(1).
Score: 0.201
-
ERS syllabus for postgraduate training in respiratory infections: a guide for comprehensive training. Breathe (Sheff). 2018 Dec; 14(4):269-275.
Score: 0.199
-
The European Multicentre Bronchiectasis Audit and Research Collaboration (EMBARC) ERS Clinical Research Collaboration. Eur Respir J. 2018 11; 52(5).
Score: 0.199
-
A comprehensive approach to lung function in bronchiectasis. Respir Med. 2018 12; 145:120-129.
Score: 0.198
-
Efficacy and effectiveness of Ceftaroline Fosamil in patients with pneumonia: a systematic review and meta-analysis. Respir Res. 2018 Oct 23; 19(1):205.
Score: 0.198
-
How to Process Sputum Samples and Extract Bacterial DNA for Microbiota Analysis. Int J Mol Sci. 2018 Oct 20; 19(10).
Score: 0.198
-
Administrative databases and clinical governance: The case of COPD. Int J Health Plann Manage. 2019 Jan; 34(1):177-186.
Score: 0.195
-
Neutrophil elastase in bronchiectasis. Respir Res. 2017 12 19; 18(1):211.
Score: 0.187
-
Non-invasive mechanical ventilation in patients with diffuse interstitial lung diseases. BMC Pulm Med. 2014 Dec 05; 14:194.
Score: 0.151
-
Highlights on the appropriate use of fluoroquinolones in respiratory tract infections. Pulm Pharmacol Ther. 2006; 19 Suppl 1:11-9.
Score: 0.081
-
Distinct Metabolic Profile Associated with a Fatal Outcome in COVID-19 Patients during the Early Epidemic in Italy. Microbiol Spectr. 2021 10 31; 9(2):e0054921.
Score: 0.060
-
Integrated longitudinal immunophenotypic, transcriptional and repertoire analyses delineate immune responses in COVID-19 patients. Sci Immunol. 2021 08 10; 6(62).
Score: 0.060
-
Prognostic parameters of in-hospital mortality in COVID-19 patients-An Italian experience. Eur J Clin Invest. 2021 Sep; 51(9):e13629.
Score: 0.060
-
Hemostatic alterations in COVID-19. Haematologica. 2021 05 01; 106(5):1472-1475.
Score: 0.059
-
Assessment of Platelet Thrombus Formation under Flow Conditions in Adult Patients with COVID-19: An Observational Study. Thromb Haemost. 2021 Aug; 121(8):1087-1096.
Score: 0.058
-
Deep vein thrombosis in COVID-19 patients in general wards: prevalence and association with clinical and laboratory variables. Radiol Med. 2021 May; 126(5):722-728.
Score: 0.058
-
Increasing dosages of low-molecular-weight heparin in hospitalized patients with Covid-19. Intern Emerg Med. 2021 08; 16(5):1223-1229.
Score: 0.058
-
The ADAMTS13-von Willebrand factor axis in COVID-19 patients. J Thromb Haemost. 2021 02; 19(2):513-521.
Score: 0.057
-
Chest X-ray findings in a large cohort of 1117 patients with SARS-CoV-2 infection: a multicenter study during COVID-19 outbreak in Italy. Intern Emerg Med. 2021 08; 16(5):1173-1181.
Score: 0.057
-
Anakinra combined with methylprednisolone in patients with severe COVID-19 pneumonia and hyperinflammation: An observational cohort study. J Allergy Clin Immunol. 2021 Feb; 147(2):561-566.e4.
Score: 0.057
-
Early detection of deep vein thrombosis in patients with coronavirus disease 2019: who to screen and who not to with Doppler ultrasound? J Ultrasound. 2021 Jun; 24(2):165-173.
Score: 0.056
-
Genomewide Association Study of Severe Covid-19 with Respiratory Failure. N Engl J Med. 2020 10 15; 383(16):1522-1534.
Score: 0.055
-
Complement activation in patients with COVID-19: A novel therapeutic target. J Allergy Clin Immunol. 2020 Jul; 146(1):215-217.
Score: 0.055
-
In Vitro Synergism of Colistin and N-acetylcysteine against Stenotrophomonas maltophilia. Antibiotics (Basel). 2019 Jul 25; 8(3).
Score: 0.052
-
Atypical pathogens in hospitalized patients with community-acquired pneumonia: a worldwide perspective. BMC Infect Dis. 2018 Dec 18; 18(1):677.
Score: 0.050
-
An international perspective on hospitalized patients with viral community-acquired pneumonia. Eur J Intern Med. 2019 02; 60:54-70.
Score: 0.050
-
Microbiological testing of adults hospitalised with community-acquired pneumonia: an international study. ERJ Open Res. 2018 Oct; 4(4).
Score: 0.049
-
In vitro activity of N-acetylcysteine against Stenotrophomonas maltophilia and Burkholderia cepacia complex grown in planktonic phase and biofilm. PLoS One. 2018; 13(10):e0203941.
Score: 0.049
-
In vitro synergism of colistin in combination with N-acetylcysteine against Acinetobacter baumannii grown in planktonic phase and in biofilms. J Antimicrob Chemother. 2018 09 01; 73(9):2388-2395.
Score: 0.049
-
Evaluation of severity score-guided approaches to macrolide use in community-acquired pneumonia. Eur Respir J. 2017 09; 50(3).
Score: 0.046
-
European Respiratory Society guidelines for the management of adult bronchiectasis. Eur Respir J. 2017 09; 50(3).
Score: 0.046
-
The European Multicentre Bronchiectasis Audit and Research Collaboration (EMBARC): experiences from a successful ERS Clinical Research Collaboration. Breathe (Sheff). 2017 Sep; 13(3):180-192.
Score: 0.046
-
Role of Streptococcus pneumoniae infection in chronic obstructive pulmonary disease patients in Italy. Ther Adv Respir Dis. 2017 10; 11(10):403-407.
Score: 0.046
-
Serotypes and antibiotic susceptibility of Streptococcus pneumoniae isolated from hospitalized patients with community-acquired pneumonia in Italy. SAGE Open Med. 2017; 5:2050312117720058.
Score: 0.045
-
Pulmonary exacerbation in adults with bronchiectasis: a consensus definition for clinical research. Eur Respir J. 2017 06; 49(6).
Score: 0.045
-
An update on the pharmacotherapeutic management of lower respiratory tract infections. Expert Opin Pharmacother. 2017 Jul; 18(10):973-988.
Score: 0.045
-
Epidemiology of clinical trials of medicines in respiratory diseases in Europe and Italy. Respir Med. 2017 04; 125:8-11.
Score: 0.044